noscript

Cardicomm Solutions, Inc. Press Releases

TSX VENTURE SYMBOL: EKG

CardioComm Solutions Names New Australian Distributor to Support GEMS™ WIN and HeartCheck™ ECG PEN Sales

Announcement coincides with first Australian hospital GEMS™ WIN license sale TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), a global medical and consumer provider of electrocardiogram ("ECG") acquisition and management software solutions, today announced it has entered into a distributor agreement with Innovative Medical Solutions ("Innovative Medical") located in Perth, Western Australia...

Cardiocomm Solutions issues stock options

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of ECG acquisition and management software solutions, today announced that it has granted an aggregate of 1,050,060 incentive stock options to members of its board of directors. 250,060 of the options are exercisable at $0.144 per share for five years from the date of grant and vest immediately, 250,000 of the options are...

CardioComm Solutions GEMS™ WIN Enables Wireless Ambulatory ECG Devices to Send Data Through Consumer Smartphones

Global agreement with IntriCon Corporation to expand GEMS™ WIN sales through access to new and cost-effective, wireless ECG devices. TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) a global medical provider of electrocardiogram ("ECG") acquisition and management software solutions, today announced it has entered into an ECG device and software distribution and marketing agreement with...

CardioComm Solutions Optimized for HeartCheck™ and GEMS WIN Sale and Operations with ISO Certification Award

Consolidated Resources will Better Serve HeartCheck™, GEMS™ WIN and New Product Sales. TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today confirmed it has received new regulatory certification from the Canadian Medical Devices Conformity Assessment System (CMDCAS) specifically for its Toronto facilities. Global Business/Product Development, Regulatory, Quality, Development, Service...

CardioComm Solutions to launch the HeartCheck™ ECG PEN with bluetooth for wireless Android and Apple smartphone connectivity

Planned launch will increase market access for device sales and ECG services globally. TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) a global medical provider of electrocardiogram ("ECG") acquisition and management software, announced today that it will introduce a Bluetooth HeartCheck™ PEN for wireless connectivity to Android and Apple Smartphones by Q1 2016. CardioComm Solutions is the...

CardioComm Solutions’ HeartCheck™ ECG PEN is Now Available for Sale in Select Rexall Pharmacies

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of electrocardiogram ("ECG") acquisition and management software solutions, announces the HeartCheck™ ECG PEN is now available on the shelves of select Rexall Pharmacies in Canada. Participating Rexall Pharmacies will display the HeartCheck™ ECG PEN in their diabetes over-the-counter (OTC) section. In-store...

CardioComm Solutions Completes Share Issuance Under HeartCheck™ PEN US Retail Pharmacy Consulting Agreement

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of ECG acquisition and management software solutions, today announced that it has issued an aggregate of 214,286 common shares of the Company at a deemed price of $0.07 per share, for a total value of $15,000, to an arm's length service provider in settlement of services provided, as previously described in the Company's...

CardioComm Solutions announces distribution and co-marketing agreement for the sale of Braemar wireless event devices utilizing GEMS™ WIN software

Global agreement will provide new hardware wireless device options for GEMS™ WIN clients. TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) a global medical provider of electrocardiogram ("ECG") acquisition and management software solutions, today announced it has entered into a three year renewable, non-exclusive, co-marketing and distribution agreement with Minneapolis based Braemar...

Cardiocomm Solutions Announces Shares For Debt Transaction And Issuance Of Stock Options

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of ECG acquisition and management software solutions, today announced that it has issued an aggregate of 50,000 common shares of the Company at a deemed price of $0.10 per share, for a total value of $5,000, to an arm’s length service provider in settlement of services provided, as previously described in the...

Cardiocomm Solutions Confirms Australian Regulatory Clearance For Over The Counter (OTC) Sales Of The Heartcheck™ ECG PEN

Cardiac Innovations Australia will promote sales of HeartCheck™ devices to medical and retail markets TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of electrocardiogram (“ECG”) acquisition and management software solutions, today announced that it has received clearance from the Australian Department of Health, Therapeutics Goods Administration...

CardioComm Solutions to Initiate Sales of the HeartCheck™ ECG PEN Device in 602 Shoppers Drug Mart Pharmacies Across Canada

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today announced that it has entered into an agreement with Shoppers Drug Mart Inc. (“Shoppers Drug Mart”) for the over-the-counter (“OTC”) sale of the HeartCheck™ ECG PEN device in pharmacies across Canada. The HeartCheck™ ECG PEN has passed regulatory reviews by both Health Canada and the US Food and Drug...

CardioComm Solutions’ Direct Sales Campaign to Place the HeartCheck™ ECG PEN on Shelves of Independent Pharmacy Retailers in Ontario.

HeartCheck™ PEN to be marketed directly to over 500 Independent Retail Pharmacies in Ontario TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of electrocardiogram ("ECG") acquisition and management software solutions, announces they have entered into an agreement with a direct-to-pharmacy sales force for the introduction of the HeartCheck™ ECG PEN for sale into...

CardioComm Solutions Re-Prices Previously Announced Equity Financing

Funding will be used as bridge financing to complete Q1 2014 objectives TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) ("CardioComm Solutions" or the "Company") today announced that it has re-priced its previously announced equity financing. The Company will now be conducting a private placement equity financing under which it intends to issue 15,000,000 units at a price of $0.0675 per unit for gross proceeds of $1,012,500. Each unit will be comprised of one...

Cardiocomm Solutions To Migrate Existing MARS® Event Software Users To GEMS™ WIN

MARS® Event Station users to upgrade to GEMS™ WIN and GEMS™ Lite Arrhythmia software in response to discontinued Windows XP and Server 2003 support Toronto, Canada  – CardioComm Solutions, Inc. ( TSX-V:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of ECG acquisition and management software solutions is pleased to announce  a four year agreement with GE Healthcare’s Diagnostic Cardiology...

CardioComm Solutions Confirms Therapeutics Goods Administration Clearance For The Sale Of GEMS™ WIN In Australia

Cardiac Innovations Australia will promote sales of CardioComm Solutions’ Software into local Hospitals and Physician Based Institutions TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of electrocardiogram (“ECG”) acquisition and management software solutions, today announced that is has signed an agency agreement with Cardiac Innovations Australia Pty....

CardioComm Solutions Announces Completion Of iMedical Sale Transaction And The Start Of Software Development For Wearable GSM And Mobile Cardiac Telemetry ECG Monitoring

The series of transactions will provide CardioComm Solutions with a recurrent and service-based royalty revenue stream TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) confirmed today that Toronto-based iMedical Innovations, Inc. (“IMED”) has finalized due diligence reviews and that the series of agreements involving custom software development and royalty license fees executed on...

CardioComm Solutions, Inc. Confirms Vendor Clearance for Sales into U.S. Federal Government Agencies and Armed Forces.

GEMS™ WIN Software and HeartCheck™ Sales Will Have Expanded Access into the United States Air Force and Other Military Establishments Toronto, Canada – CardioComm Solutions, Inc. (TSX-V:EKG) (“CardioComm Solutions” or the “Company”),CardioComm Solutions today announced that it has become an approved vendor for the sale of their HeartCheck™ products and ECG-based software solutions into numerous organizations within the umbrella of...

CardioComm Solutions to Launch HeartCheck™ Technology for Atrial Fibrillation Screening and Stroke Prevention Trial in Canadian Rexall Pharmacies

CIHR, Industry and Heart and Stroke funded study will start with in-pharmacy screening in October 2014 Toronto, Canada – CardioComm Solutions, Inc. (TSX-V:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of electrocardiogram (“ECG”) acquisition and management software solutions, today announced it has completed its technology placement for the Canadian Stroke Prevention Intervention Network (“C-SPIN”)...

CARDIOCOMM SOLUTIONS AND THE HEART AND STROKE FOUNDATION OF CANADA PARTNER TO PERFORM COMMUNITY BASED ECG SCREENING IN SUPPORT OF THE “SCREEN FOR ATRIAL FIBRILLATION EVERYWHERE (SAFE)” STUDY.

Screening efforts designed to increase awareness and provide education of the warning signs and implications of Atrial Fibrillation as a risk factor for stroke. TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) CardioComm Solutions and the Heart and Stroke Foundation are working together to implement the Company's SMART Monitoring based HeartCheck™ ECG screening solution at four trade shows in...

CARDIOCOMM SOLUTIONS EXECUTES CUSTOM SOFTWARE DEVELOPMENT AND ROYALTY AGREEMENTS WITH IMEDICAL INNOVATIONS, INC. FOR WEARABLE GSM ENABLED ECG MONITORING

Custom Software Will Target the Growing Mobile Cardiac Telemetry (MCT) ECG Monitoring and Consumer Use Markets TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) confirmed today that they have executed a series of agreements involving a custom software development and royalty license with the newly formed and Toronto-based iMedical Innovations, Inc. ("IMED"). On September 15, 2014, the two...

CARDIOCOMM SOLUTIONS IS LISTED BY THE FAA CIVIL AEROSPACE MEDICAL INSTITUTE AS AN ECG CLOUD SERVICES PROVIDER FOR USE BY AIR MEDICAL EXAMINERS

ECG Modernization Project Links CardioComm Solutions to the FAA Aviation Medical Examiner (AME) Community TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today confirmed that it has been listed as a cloud services provider under the launch of the Federal Aviation Administration (“FAA”) Civil Aerospace Medical Institute ECG Modernization project. The specific product involved is the...

UK-based Arrhythmia Alliance to Highlight CardioComm Solutions’ HeartCheckTM PEN ECG Device on its Website

Web-Presence will introduce the HeartCheck™ device to a global network of patients and affiliate organizations TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of electrocardiogram (“ECG”) acquisition and management software solutions, today announced an agency agreement with Arrhythmia Alliance based out of the United Kingdom.  The Arrhythmia...

GEMS™ WIN For Windows 7 Software Upgrade Launch Yields Early Wins For Cardiocomm Solutions, Inc.

Active sales and marketing efforts of GEMS™ WIN as a Windows 7 compatible ECG management software nets new license agreements from a wide array of customers TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today announced that sales of its new Global ECG Management System release (GEMS™  WIN), a Windows 7 compatible version of the Company’s GEMS™ software technology, is...

CardioComm Solutions, Inc. Completing Corporate Restructuring to Focus on Sales and Marketing

Company Shifts Focus from R&D to Increased Resourcing of ECG Software Sales and Customer Support TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), today announced operations and sales team changes intended to drive inside-sales through upgrading the Company's medical software customers to the new Windows 7 compatible Global ECG Management System software (GEMS™ WIN) and the Company's...

Pharmacy.ca To Provide Internet-Based Pharmacy Sales Of Cardiocomm Solutions’ Heartcheck™ Pen ECG Device

Web-based site provides access to the HeartCheck™ PEN by Canadians who are without easy access to pharmacies TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of electrocardiogram (“ECG”) acquisition and management software solutions, today announced a distribution agreement with Toronto-based PHARMACY.CA, for internet-based sales of the HeartCheck™...

CardioComm Solutions Closes Equity Financing

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE: EKG) (“CardioComm Solutions” or the “Company”) announced today it had closed the first tranche of its previously announced private placement equity financing.  Under the closing of the first tranche, the Company issued 3,300,000 units at a price of $0.05 per unit, for gross proceeds of $165,000.  Each unit was comprised of one common share of the Company and one common share purchase...


ECG Monitoring Made Easy

Receive accurate electrocardiogram (‘ECG’ or ‘EKG’) readings in as few as 30 seconds that can then be sent instantly to a physician for review.